Mia's Feed
Medical News & Research

Revolutionizing Eye Care: Innovative Approaches for a Brighter Vision Future

Revolutionizing Eye Care: Innovative Approaches for a Brighter Vision Future

Share this article

Kruti Naik from Wits University is developing cutting-edge microneedle and nanomedicine technologies to improve eye infection treatment, offering safer, more effective solutions to prevent blindness globally.

2 min read

In a significant leap forward for ocular health, researcher Kruti Naik from Wits University is pioneering novel treatment methods that could transform how eye infections and diseases are managed. Traditionally, eye drops are the primary treatment for many eye conditions, but Naik is exploring more efficient, affordable alternatives using cutting-edge nanomedicine and microneedle technologies.

With a substantial portion of the global population, especially in Africa, facing blindness—due to untreated communicable infections like HIV-related conditions and non-communicable diseases such as diabetes and hypertension—these advancements are crucial. Naik’s research envisions tiny, contact lens-like patches embedded with micro-scale needles that can deliver medication painlessly directly to the front part of the eye. This approach minimizes medication waste, eliminates the need for refrigeration—a major challenge in resource-limited settings—and ensures targeted, sustained drug delivery.

The potential of microneedles extends beyond drug delivery; they can be integrated with nanomedicine to develop smart, biodegradable, and biocompatible systems capable of treating a range of eye conditions, including infections, degenerative diseases, and inflammatory disorders. Naik emphasizes that this technology could be life-changing, particularly by providing prompt and effective treatment that prevents blindness.

Currently collaborating with experts at Queen's University Belfast, Naik is working on peptide-based hydrogels that can self-assemble to fight infections and act as long-lasting implants for steady medication release. Her work, supported by the Wits Foundation UK and supervised by prominent professors, highlights how innovative biomedical engineering can make treatments less invasive and more accessible.

Naik’s broader vision is to adapt this technology to other diseases, including cancer, demonstrating the versatility of her approach. Her prior studies show that these hydrogels are safe, stable, and capable of reducing multiple invasive procedures by acting as sustained drug depots within the eye.

As a female scientist leading impactful research, Naik’s work embodies the vital role of women in advancing medical science. Her focus on patient-centric and accessible healthcare solutions underscores the importance of developing treatments that are effective in real-world settings, especially for vulnerable populations such as women and children in Africa.

This innovative research underscores a future where eye care is more precise, less invasive, and globally accessible, potentially saving countless individuals from vision loss.

Stay Updated with Mia's Feed

Get the latest health & wellness insights delivered straight to your inbox.

How often would you like updates?

We respect your privacy. Unsubscribe at any time.

Related Articles

High Undiagnosed Rates of Autism in Middle-Aged and Older Adults in the UK Highlight Critical Gaps

A groundbreaking review from King's College London reveals that nearly 90% of autistic adults over 40 in the UK are undiagnosed, exposing critical gaps in healthcare and support for aging populations.

FDA Approves Zynyz as First-Line Therapy for Advanced Anal Cancer

The FDA has approved Zynyz, a PD-1 inhibitor, as the first-line treatment for advanced anal cancer, offering new hope for patients with limited options and demonstrating significant clinical benefits based on recent trial results.

Advanced Bat Organoid Platform Enhances Pandemic Preparedness Through Novel Virus Research

A newly developed comprehensive bat organoid platform enables detailed study of zoonotic viruses, advancing pandemic preparedness and virus research through scalable, multi-species tissue models.

Cell Defects in Exosomes Implicated in Alzheimer's Disease Development

New research links defects in exosome production caused by SORLA mutations to the development of Alzheimer's disease, opening potential avenues for innovative treatments.